Description
The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt certain uses of Fluticasone propionate.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice: Prescription Drug List (PDL): Fluticasone propionate | HTML | Open resource | |
| Notice: Prescription Drug List (PDL): Fluticasone propionate | HTML | Open resource |